CXCL8 and hepatocellular carcinoma: Furthermore, the association between IL-8 (-251T/A) polymorphism and other cancers, such as melanoma [51], hepatocellular carcinoma [52], ovarian cancer [53], and breast cancer [54], has been confirmed.